肺微生物群:从健康的肺部到慢性阻塞性肺病的发展
1Group for Molecular Biology, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, 11042 Belgrade, Serbia.
International journal of molecular sciences
|February 26, 2025
概括
肺部微生物群,包括细菌,真菌和病毒,对肺部免疫至关重要. 慢性阻塞性肺病 (COPD) 涉及肺功能失调,影响疾病进展,并强调需要进一步研究宿主微生物群相互作用.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 肺部健康依赖于复杂的肺微生物群 (细菌生物群,菌生物群,病毒群).
- 肺部微生物群调节先天性和适应性免疫力,对宿主保护至关重要.
- 慢性阻塞性肺病 (COPD) 的特点是肺功能失调,改变了微生物群的组成和多样性.
研究的目的:
- 综合审查肺微生物群的组成.
- 探索COPD中宿主微生物群相互作用的分子机制和临床方面.
- 讨论肠肺轴的作用和潜在的治疗应用,如COPD中的益生菌.
主要方法:
- 对肺微生物群和COPD研究的文献综述.
- 分析COPD中拟议的失活性模型 (例如,炎症周期,细菌相互作用体).
- 检查COPD病变发生过程中的宿主-微生物群和微生物-微生物相互作用.
主要成果:
- 肺功能失调随着COPD的进展和恶化而恶化.
- 提出了两种失生症模型 (炎症循环,破坏细菌相互作用体).
- 肠肺轴在肺部健康中起着至关重要的作用,并与COPD有关.
结论:
- 了解肺微生物群的组成和相互作用是COPD病原体的关键.
- 需要进一步探索宿主-微生物群和微生物-微生物机制.
- 益生菌的应用对未来的COPD治疗有希望.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
01:22Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170